<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00953212</url>
  </required_header>
  <id_info>
    <org_study_id>MMC-3514</org_study_id>
    <nct_id>NCT00953212</nct_id>
  </id_info>
  <brief_title>Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery</brief_title>
  <official_title>A Randomized Controlled Trial to Compare Prophylaxis With Oral Ascorbic Acid, Oral Amiodarone or Both in Combination With Beta Blockers to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maine Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maine Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial Fibrillation (AF) is a common postoperative complication of cardiac surgery, occuring
      in approximately 25-30% of coronary artery bypass graft (CABG) patients and 35-40% of heart
      valve repair/replacement patients. Efforts to decrease the high rates of AF have not made
      great inroads to the problem. The current standard of care is the use of preoperative and
      postoperative beta blockers. We propose to compare the use of prophylactic oral ascorbic acid
      with and without prophylactic oral amiodarone, in combination with oral beta blockers, for
      the prevention of atrial fibrillation after open heart surgery. The hypothesis is that either
      drug, or a combination of the two drugs, will be superior and safe when compared to beta
      blockers alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial fibrillation is a common complication of cardiac surgery which is associated with
      increased morbidity, length of stay and cost. Efforts to mitigate this problem with beta
      blockers and amiodarone have been met with limited success. Observational data suggests that
      prophylactic amiodarone has been helpful in decreasing the incidence of AF as well as
      increasing its ease of management. The opportunity to use ascorbic acid for AF prophylaxis is
      attractive because of its low side effect profile, wide acceptance and low cost.

      We have designed a prospective, randomized, controlled trial using a 2 X 2 factorial design
      to determine whether prophylactic ascorbic acid alone, ascorbic acid with amiodarone, or
      amiodarone alone, when given along with beta blockers will decrease the incidence of
      postoperative AF in adult cardiac surgery in all comers as compared with beta blockers alone.

      Patients will be randomized into four groups, A, B, C, and D. All groups will receive beta
      blockers, Group A will receive beta blockers, ascorbic acid, and amiodarone, Group B will
      receive ascorbic acid and Beta blockers, Group C will receive amiodarone and beta blockers
      and Group D will receive only beta blockers.

      Success of randomization will be assessed by comparing treatment groups with respect to
      baseline characteristics, using t-tests or their nonparametric equivalent (as appropriate)
      for continuous variables and chisquare tests or Fisher's exact tests for categorical
      variables. The primary hypotheses of the effects of ascorbic acid and amiodarone on incidence
      of atrial fibrillation will be tested using chisquare tests for differences in proportions.
      No adjustment will be made for multiple comparisons since both hypotheses are pre-specified.
      We will use exploratory analyses including stratification to assess for the possibility of
      effect modification between ascorbic acid and amiodarone. If an interaction is suggested by
      these analyses, we will use logistic regression with a cross-product term as a formal
      statistical test for interaction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of Post-operative Atrial Fibrillation Requiring Treatment After Open Heart Surgery</measure>
    <time_frame>5 postoperative days</time_frame>
    <description>Atrial fibrillation is a common complication of cardiac surgery which is associated with increased morbidity, length of stay and cost. The opportunity to use ascorbic acid for AF prophylaxis is attractive because of its low side effect profile, wide acceptance and low cost. This prospective, randomized trial used a 2 X 2 factorial design to determine whether prophylactic ascorbic acid alone, ascorbic acid with amiodarone, or amiodarone alone, when given along with beta blockers would decrease the incidence of postoperative AF in adult cardiac surgery when compared with beta blockers alone, all combinations failed to show any difference between the four groups. While there have been trials that have shown the addition of amiodarone to beta-blockers to be more effective, this analysis does not support that conclusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality measured within length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Length of Stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Stroke</measure>
    <time_frame>30 days</time_frame>
    <description>Cerebral vascular accident occurring within hospital length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Low Output Heart Failure</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Postoperative Vasoplegia</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Respiratory Failure Requiring Reintubation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Bradycardia Necessitating Permanent Pacemaker Placement</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Acute Kidney Injury</measure>
    <time_frame>30 days</time_frame>
    <description>Using the Akin definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Readmission to ICU for Treatment of Atrial Fibrillation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Readmission to Hospital for Treatment of Atrial Fibrillation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">304</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beta Blockers, Ascorbic Acid and Amiodarone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beta Blockers and Ascorbic Acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beta Blockers and Amiodarone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beta Blockers alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>beta blockers</intervention_name>
    <description>metoprolol 25mg by mouth every 6 hours</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
    <other_name>Lopressor</other_name>
    <other_name>Toprol XL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>amiodarone</intervention_name>
    <description>amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Cordarone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ascorbic acid</intervention_name>
    <description>ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <other_name>vitamin C</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults (18 years of age or older)

          -  all comers for elective or urgent open heart surgery ( CABG, Valve repair or
             replacement, Combined CABG/Valves, CABG/other, Other)

        Exclusion Criteria:

          -  patients who refuse to participate

          -  patients with a history of atrial fibrillation or atrial flutter

          -  pediatric patients (under 18 years of age)

          -  Emergency surgery

          -  patients with contraindications to study medications

          -  patients with untreated thyroid disease, hepatic failure, pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter C Donovan, PA-C, MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maine Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert S Kramer, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Maine Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2009</study_first_submitted>
  <study_first_submitted_qc>August 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <results_first_submitted>January 22, 2018</results_first_submitted>
  <results_first_submitted_qc>March 1, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 29, 2018</results_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maine Medical Center</investigator_affiliation>
    <investigator_full_name>Peter C. Donovan</investigator_full_name>
    <investigator_title>Staff Physician Assistant, Cardiothoracic Surgery</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>open heart surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Adrenergic beta-Antagonists</mesh_term>
    <mesh_term>Amiodarone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Beta Blockers, Ascorbic Acid and Amiodarone</title>
          <description>beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
        </group>
        <group group_id="P2">
          <title>Beta Blockers and Ascorbic Acid</title>
          <description>Beta Blockers and Ascorbic Acid beta blockers: metoprolol 25mg by mouth every 6 hours
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
        </group>
        <group group_id="P3">
          <title>Beta Blockers and Amiodarone</title>
          <description>Beta Blockers and Amiodarone
beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively</description>
        </group>
        <group group_id="P4">
          <title>Beta Blockers Alone</title>
          <description>Beta Blockers alone
beta blockers: metoprolol 25mg by mouth every 6 hours</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="74"/>
                <participants group_id="P3" count="78"/>
                <participants group_id="P4" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="74"/>
                <participants group_id="P3" count="78"/>
                <participants group_id="P4" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group A</title>
          <description>Beta Blockers, Ascorbic Acid and Amiodarone
beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
        </group>
        <group group_id="B2">
          <title>Group B</title>
          <description>Beta Blockers and Ascorbic Acid
beta blockers: metoprolol 25mg by mouth every 6 hours
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
        </group>
        <group group_id="B3">
          <title>Group C</title>
          <description>Beta Blockers and Amiodarone
beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively</description>
        </group>
        <group group_id="B4">
          <title>Group D</title>
          <description>Beta Blockers alone
beta blockers: metoprolol 25mg by mouth every 6 hours</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="78"/>
            <count group_id="B4" value="76"/>
            <count group_id="B5" value="304"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.3" spread="9.6"/>
                    <measurement group_id="B2" value="65.9" spread="9.4"/>
                    <measurement group_id="B3" value="63.9" spread="10.7"/>
                    <measurement group_id="B4" value="33.4" spread="931"/>
                    <measurement group_id="B5" value="61" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="74"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="56"/>
                    <measurement group_id="B5" value="230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="77"/>
                    <measurement group_id="B4" value="75"/>
                    <measurement group_id="B5" value="302"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoker</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (mean, SD)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.6" spread="6.1"/>
                    <measurement group_id="B2" value="31.1" spread="5.7"/>
                    <measurement group_id="B3" value="27.9" spread="4.7"/>
                    <measurement group_id="B4" value="29.5" spread="6.2"/>
                    <measurement group_id="B5" value="29.7" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiovascular Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="65"/>
                    <measurement group_id="B5" value="259"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-op Myocardial Infarction</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="35"/>
                    <measurement group_id="B5" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="27"/>
                    <measurement group_id="B5" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peripheral Vascular Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic Obstructive Pulmonary Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Statin</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Congestive Heart Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgery Type - CABG</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="55"/>
                    <measurement group_id="B4" value="58"/>
                    <measurement group_id="B5" value="232"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgery Type - Valve</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgery Type - CABG/Valve</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgery Type - Other</title>
          <description>Other surgeries include ascending aortic repair, myxoma excision, patent ductus foramen ovale closure, or endarterectomy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Urgent Surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="71"/>
                    <measurement group_id="B4" value="73"/>
                    <measurement group_id="B5" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Post-operative Atrial Fibrillation Requiring Treatment After Open Heart Surgery</title>
        <description>Atrial fibrillation is a common complication of cardiac surgery which is associated with increased morbidity, length of stay and cost. The opportunity to use ascorbic acid for AF prophylaxis is attractive because of its low side effect profile, wide acceptance and low cost. This prospective, randomized trial used a 2 X 2 factorial design to determine whether prophylactic ascorbic acid alone, ascorbic acid with amiodarone, or amiodarone alone, when given along with beta blockers would decrease the incidence of postoperative AF in adult cardiac surgery when compared with beta blockers alone, all combinations failed to show any difference between the four groups. While there have been trials that have shown the addition of amiodarone to beta-blockers to be more effective, this analysis does not support that conclusion.</description>
        <time_frame>5 postoperative days</time_frame>
        <population>Number of patients who experienced Atrial Fibrillation post-operatively</population>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Post-operative Atrial Fibrillation Requiring Treatment After Open Heart Surgery</title>
          <description>Atrial fibrillation is a common complication of cardiac surgery which is associated with increased morbidity, length of stay and cost. The opportunity to use ascorbic acid for AF prophylaxis is attractive because of its low side effect profile, wide acceptance and low cost. This prospective, randomized trial used a 2 X 2 factorial design to determine whether prophylactic ascorbic acid alone, ascorbic acid with amiodarone, or amiodarone alone, when given along with beta blockers would decrease the incidence of postoperative AF in adult cardiac surgery when compared with beta blockers alone, all combinations failed to show any difference between the four groups. While there have been trials that have shown the addition of amiodarone to beta-blockers to be more effective, this analysis does not support that conclusion.</description>
          <population>Number of patients who experienced Atrial Fibrillation post-operatively</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="58"/>
                    <measurement group_id="O4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Mortality</title>
        <description>Mortality measured within length of hospital stay</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Beta Blockers, Ascorbic Acid and Amiodarone</title>
            <description>beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
          </group>
          <group group_id="O2">
            <title>Beta Blockers and Ascorbic Acid</title>
            <description>Beta Blockers and Ascorbic Acid beta blockers: metoprolol 25mg by mouth every 6 hours
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
          </group>
          <group group_id="O3">
            <title>Beta Blockers and Amiodarone</title>
            <description>Beta Blockers and Amiodarone
beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively</description>
          </group>
          <group group_id="O4">
            <title>Beta Blockers Alone</title>
            <description>Beta Blockers alone
beta blockers: metoprolol 25mg by mouth every 6 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Mortality</title>
          <description>Mortality measured within length of hospital stay</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Length of Stay</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="4.8"/>
                    <measurement group_id="O2" value="6.6" spread="3.8"/>
                    <measurement group_id="O3" value="6.8" spread="3.6"/>
                    <measurement group_id="O4" value="6.8" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ICU Length of Stay</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>ICU Length of Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="1.5"/>
                    <measurement group_id="O2" value="1.9" spread="1.3"/>
                    <measurement group_id="O3" value="2.0" spread="1.3"/>
                    <measurement group_id="O4" value="1.9" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Stroke</title>
        <description>Cerebral vascular accident occurring within hospital length of stay</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Stroke</title>
          <description>Cerebral vascular accident occurring within hospital length of stay</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Low Output Heart Failure</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Low Output Heart Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Postoperative Vasoplegia</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Postoperative Vasoplegia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Respiratory Failure Requiring Reintubation</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Respiratory Failure Requiring Reintubation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Bradycardia Necessitating Permanent Pacemaker Placement</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Bradycardia Necessitating Permanent Pacemaker Placement</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Acute Kidney Injury</title>
        <description>Using the Akin definition</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Acute Kidney Injury</title>
          <description>Using the Akin definition</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Readmission to ICU for Treatment of Atrial Fibrillation</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Readmission to ICU for Treatment of Atrial Fibrillation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Readmission to Hospital for Treatment of Atrial Fibrillation</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amiodarone - Yes</title>
            <description>Patients who were administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O2">
            <title>Amiodarone - No</title>
            <description>Patients who were not administered Amiodarone and Beta Blockers with or without Ascorbic Acid.</description>
          </group>
          <group group_id="O3">
            <title>Ascorbic Acid - Yes</title>
            <description>Patients who were administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
          <group group_id="O4">
            <title>Ascorbic Acid - No</title>
            <description>Patients who were not administered Ascorbic Acid and Beta Blockers with or without Amiodarone.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Readmission to Hospital for Treatment of Atrial Fibrillation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="150"/>
                <count group_id="O4" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group A</title>
          <description>Beta Blockers, Ascorbic Acid and Amiodarone
beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
        </group>
        <group group_id="E2">
          <title>Group B</title>
          <description>Beta Blockers and Ascorbic Acid
beta blockers: metoprolol 25mg by mouth every 6 hours
ascorbic acid: ascorbic acid 2,000mg by mouth evening before surgery ascorbic acid 2,000mg by mouth morning of surgery ascorbic acid 1,000mg by mouth every 12 hours for 5 postoperative days</description>
        </group>
        <group group_id="E3">
          <title>Group C</title>
          <description>Beta Blockers and Amiodarone
beta blockers: metoprolol 25mg by mouth every 6 hours
amiodarone: amiodarone 600mg by mouth evening before surgery amiodarone 600mg by mouth morning of surgery amiodarone 400mg by mouth every 12 hours for 3 days postoperatively</description>
        </group>
        <group group_id="E4">
          <title>Group D</title>
          <description>Beta Blockers alone
beta blockers: metoprolol 25mg by mouth every 6 hours</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="76"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral Vascular Accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="74"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="78"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="29" subjects_affected="29" subjects_at_risk="76"/>
                <counts group_id="E2" events="29" subjects_affected="29" subjects_at_risk="74"/>
                <counts group_id="E3" events="21" subjects_affected="21" subjects_at_risk="78"/>
                <counts group_id="E4" events="27" subjects_affected="27" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert Kramer</name_or_title>
      <organization>Maine Medical Center</organization>
      <phone>207-662-2923</phone>
      <email>KRAMER@mmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

